Clinical Trial Update: Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients [NA]

View source ↗

Summary

Study investigating factors that influence virological response after stopping nucleoside analogue therapy in chronic hepatitis B patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: St Vincent's Hospital Melbourne | Conditions: Chronic Hepatitis B. | NA | Status: UNKNOWN